Sushko Katelyn, Sherifali Diana, Smith Kelly, Lipscombe Lorraine L
Women's College Research and Innovation Institute, Women's College Hospital, Toronto, Canada
School of Nursing, McMaster University, Hamilton, Canada.
BMJ Open. 2025 May 6;15(5):e088811. doi: 10.1136/bmjopen-2024-088811.
Women with a history of gestational diabetes mellitus (GDM) have a high lifetime risk of developing type 2 diabetes. Diabetes prevention programmes may reduce this risk. However, challenges related to the successful implementation of diabetes prevention programmes after GDM exist. Our objective is to map the components of the effective implementation of diabetes prevention programmes after GDM. We also plan to connect the available evidence on the effective implementation of diabetes prevention programmes to the Consolidated Framework for Implementation Research.
We will conduct a scoping review following Levac's adaptation of Arksey and O'Malley's framework for scoping reviews. We will report it according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews. Using a peer-reviewed search strategy, we will search Medline, Embase, PsycInfo and Emcare for primary studies describing the effective implementation of diabetes prevention programmes after GDM. Study selection will be completed in DistillerSR by two independent reviewers. Data will be extracted by one reviewer and verified by a second reviewer for accuracy using data extraction forms in DistillerSR.
Ethics approval was not required. Study results will be published in a peer-reviewed journal and presented at relevant conferences.
This scoping review protocol was registered with Open Science Framework (OSF; preregistration, 15 April 2024; registration ID: 10.17605/OSF.IO/MPNQD).
有妊娠期糖尿病(GDM)病史的女性一生中患2型糖尿病的风险很高。糖尿病预防计划可能会降低这种风险。然而,在GDM后成功实施糖尿病预防计划存在挑战。我们的目标是梳理GDM后糖尿病预防计划有效实施的组成部分。我们还计划将关于糖尿病预防计划有效实施的现有证据与实施研究综合框架联系起来。
我们将按照Levac对Arksey和O'Malley的范围审查框架的改编进行范围审查。我们将根据系统评价和Meta分析扩展的范围审查的首选报告项目进行报告。使用经过同行评审的检索策略,我们将在Medline、Embase、PsycInfo和Emcare中检索描述GDM后糖尿病预防计划有效实施的原始研究。研究选择将由两名独立评审员在DistillerSR中完成。数据将由一名评审员提取,并由另一名评审员使用DistillerSR中的数据提取表进行准确性验证。
无需伦理批准。研究结果将发表在同行评审期刊上,并在相关会议上展示。
本范围审查方案已在开放科学框架(OSF;预注册,2024年4月15日;注册ID:10.17605/OSF.IO/MPNQD)注册。